While Botox continues to be a popular choice for anti-aging treatments, it can do more than just fight wrinkles. Many physicians use Botox for its off-label uses including treating migraines, for stopping excessive sweating, and also for correcting crossed eyes. 14 European Union states have approved Botox for the treatment of urinary incontinence, or bladder problems, in those who have spinal cord injuries or multiple sclerosis and Botox may soon be approved in the United States to treat similar problems.
Trials and tests in Europe show that just a single Botox injection directly into the bladder can help patients who are suffering from the effects of urinary continence by increasing bladder capacity and preventing the contractions that make them feel like they need to use the restroom. These trials were only conducted on patients who were experiencing urinary incontinence because of spinal cord damage or multiple sclerosis, and results of these studies show that the patients noticed a significant relief in symptoms for up to nine months after their injection.
The positive outcome of these trials show that Botox can improve quality of life and Allergan, the manufacturer of Botox, is expecting to receive approval from the United States to use the injection for off-label use later this year.
Traditional treatments for urinary incontinence include prescription drugs and other types of medication, but none of the traditional treatments have produced the same level of results as Botox injections. Allergan is hoping to branch out beyond the anti-aging market so that Botox injections can be used to treat patients who are suffering from overactive bladders.